Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ELVN | Enliven Therapeutics, Inc. | Chief Scientific Officer | $30M | -$3.17M | -9.54% | Jul 31, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|